Li-jing Tang
No.110 Xiangya Road
Changsha, 410078, China
Changsha, 410078, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Sorafenib-induced cardiovascular toxicity: A cause for concern.
Journal: Chemico-biological interactions
Published: July 31, 2024
DL-3-n-butylphthalide improves the endothelium-dependent vasodilation in high-fat diet-fed ApoE-/- mice via suppressing inflammation, endothelial necroptosis and apoptosis.
Journal: European journal of pharmacology
Published: March 07, 2023
Inhibition of MALT1 reduces ferroptosis in rat hearts following ischemia/reperfusion via enhancing the Nrf2/SLC7A11 pathway.
Journal: European journal of pharmacology
Published: January 20, 2023
The SPATA2/CYLD pathway contributes to doxorubicin-induced cardiomyocyte ferroptosis via enhancing ferritinophagy.
Journal: Chemico-biological interactions
Published: August 23, 2022
Combination of ponatinib with deferoxamine synergistically mitigates ischemic heart injury via simultaneous prevention of necroptosis and ferroptosis.
Journal: European journal of pharmacology
Published: November 15, 2020
Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53/TfR1 pathway in the rat hearts after ischemia/reperfusion.
Journal: Free radical biology & medicine
Published: June 21, 2020
Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 16, 2020
Upregulation of mitochondrial E3 ubiquitin ligase 1 in rat heart contributes to ischemia/reperfusion injury.
Journal: Canadian journal of physiology and pharmacology
Published: December 12, 2019
Arctiin protects rat heart against ischemia/reperfusion injury via a mechanism involving reduction of necroptosis.
Journal: European journal of pharmacology
Published: December 03, 2019
Inhibition of Phosphoglycerate Mutase 5 Reduces Necroptosis in Rat Hearts Following Ischemia/Reperfusion Through Suppression of Dynamin-Related Protein 1.
Journal: Cardiovascular drugs and therapy
Published: January 15, 2019
Fasudil ameliorates the ischemia/reperfusion oxidative injury in rat hearts through suppression of myosin regulatory light chain/NADPH oxidase 2 pathway.
Journal: European journal of pharmacology
Published: October 29, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026